Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Fish

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Medical Hypotheses|July 1, 1975
Cancer detection with human peripheral lymphocytes: a word of cautionR G Fish
Lancet (London, England)|September 22, 1973
A possible in-vitro blood test for cancerR G Fish
Medical Hypotheses|February 1, 1996
Role of gangliosides in tumour progression: a molecular target for cancer therapy?R G Fish
Annals of Clinical Biochemistry|November 1, 1985
Dihydrofolate reductase inhibition assay for methotrexateM Edwards, R G Fish
Annals of Clinical Biochemistry|May 1, 1986
Evaluation of an immunoradiometric assay for the detection of an ovarian tumour marker, CA125, in serumM D Shelley, R G Fish
Clinical Biochemistry|February 1, 1982
Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapyR G Fish, A K Yap, K James
Melanoma Research|January 16, 1998
Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell linesL Blackstaffe, M D Shelley, R G Fish
Antimicrobial Agents and Chemotherapy|February 1, 1985
Biliary excretion of platinum in a patient treated with cis-dichlorodiammineplatinum (II)M D Shelley, R G Fish, M Adams
European Journal of Clinical Pharmacology|January 1, 1987
A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatinH Griffiths, M D Shelley, R G Fish
Therapeutic Drug Monitoring|January 1, 1984
Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II)R G Fish, M D Shelley, H Griffiths
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Medical Hypotheses|July 1, 1975
Cancer detection with human peripheral lymphocytes: a word of cautionR G Fish
Lancet (London, England)|September 22, 1973
A possible in-vitro blood test for cancerR G Fish
Medical Hypotheses|February 1, 1996
Role of gangliosides in tumour progression: a molecular target for cancer therapy?R G Fish
Annals of Clinical Biochemistry|November 1, 1985
Dihydrofolate reductase inhibition assay for methotrexateM Edwards, R G Fish
Annals of Clinical Biochemistry|May 1, 1986
Evaluation of an immunoradiometric assay for the detection of an ovarian tumour marker, CA125, in serumM D Shelley, R G Fish
Clinical Biochemistry|February 1, 1982
Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapyR G Fish, A K Yap, K James
Melanoma Research|January 16, 1998
Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell linesL Blackstaffe, M D Shelley, R G Fish
Antimicrobial Agents and Chemotherapy|February 1, 1985
Biliary excretion of platinum in a patient treated with cis-dichlorodiammineplatinum (II)M D Shelley, R G Fish, M Adams
European Journal of Clinical Pharmacology|January 1, 1987
A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatinH Griffiths, M D Shelley, R G Fish
Therapeutic Drug Monitoring|January 1, 1984
Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II)R G Fish, M D Shelley, H Griffiths
Pageof 3